BioSciences
Recent news mentioning BioSciences
- — Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
- — Pillar Biosciences Appoints Todd Christian and Yann Echelard, Ph.D., to Its Board of Directors
- — Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
- — IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences
- — Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
- — Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
- — IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
- — 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
- — IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- — Pillar Biosciences and Hamilton Expand Automated NGS Library Preparation Method for oncoReveal® Nexus 21 Gene Panel on Hamilton Microlab STAR™ and STARlet™ Liquid Handling Systems
- — Altesa BioSciences Named Recipient of the 2026 Georgia Life Sciences Golden Helix Award for Financing Deal of the Year
- — Keymed Biosciences anuncia los resultados del primer semestre de 2026 y novedades empresariales